Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership

David A. Wood*, Ehtisham Mahmud, Vinod H. Thourani, Janarthanan Sathananthan, Alice Virani, Athena Poppas, Robert A. Harrington, Joseph A. Dearani, Madhav Swaminathan, Andrea M. Russo, Ron Blankstein, Sharmila Dorbala, James Carr, Sean Virani, Kenneth Gin, Alan Packard, Vasken Dilsizian, Jean François Légaré, Jonathon Leipsic, John G. WebbAndrew D. Krahn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)971-976
Number of pages6
JournalCanadian Journal of Cardiology
Volume36
Issue number7
DOIs
StatePublished - Jul 2020

Funding

Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Keywords

  • COVID-19 pandemic
  • cardiac computed tomography
  • cardiac magnetic resonance imaging
  • cardiovascular procedures
  • cardiovascular surgery
  • diagnostic tests
  • echocardiography
  • electrophysiology
  • interventional cardiology
  • nuclear cardiac imaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this